Charles River Laboratories International Inc - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Charles River Laboratories International Inc. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Charles River Laboratories International Inc. The Group's principal activity is providing solutions that accelerate the drug discovery and development process. It partners with global pharmaceutical and biotechnology companies, government agencies and academic institutions worldwide in order to bring drugs to market faster and more efficiently. The Group currently operates approximately 70 facilities in 15 countries worldwide. Its activities are carried out through two segments: Preclinical Services (PCS) and Research Models and Services (RMS). PCS includes development services which enable customers to accelerate their drug discovery and development process. RMS includes its research model business, research model services, vaccine support services and in vitro technology services. The Group has operations in the United States, Canada, Scotland, Ireland, United Kingdom, France, Germany, Japan and Mexico.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report